CDKN1A and cervical carcinoma: In human cervical cancer HeLa cells, Alteronol inhibited cell proliferation by causing G1 phase cell cycle arrest, which was associated with reduced expression of CDK2, CDK4, cyclin D1 and an increased p21cip1/waf1 expression (13).